We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Futura Medical Plc | LSE:FUM | London | Ordinary Share | GB0033278473 | ORD 0.2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.05 | 0.14% | 35.45 | 35.20 | 35.60 | 35.65 | 35.20 | 35.45 | 246,675 | 16:35:25 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -5.85M | -0.0194 | -18.14 | 105.85M |
Date | Subject | Author | Discuss |
---|---|---|---|
10/10/2023 08:51 | LOL!!!!! A very very generous grant of options to the already extremely well paid directors. AIM gravy train Pigs in troughs OINK OINK!! Nice to see at least there's someone making money out of selling this junk, eh? SP on a cliff edge, will only take a few sells to open the trap door. Level 2 VERY weak! | thebutler | |
09/10/2023 07:53 | Erexon: 261 out of 344 (76%) reviewers recommend this product Eroxon: 285 out of 384 (74.22%) reviewers don't recommend this product | glavey | |
07/10/2023 17:28 | Lol Utterly clueless. | broomrigg | |
07/10/2023 11:44 | LOL.....thebutler's hot tip OSB, "a steal" at 500p, closed the week below 300p and there looks like very little support or confidence over there. The only thing supporting the price (slowing the collapse) is the company's own share buy-backs and how long can they keep that up for? The shares have almost halved in just a few weeks. Clearly better to have your money in FUM. | broomrigg | |
07/10/2023 08:55 | So very very close to falling into the 30s, and on the back of a small number of tiny sells. Level 2 continues to be very weak. Won't take much selling for 40p to break then there seems to be a vacuum of support. Odds on 30s this week imo. | thebutler | |
04/10/2023 20:26 | LOL, these last two reviews on Boots say it all: 5 out of 5 stars. Worked with no side effects. SJC99 10 hours ago Eroxon gel worked for me really well. Also it didn't give me the worrying breathing problems that pills have caused me in the past. Did you receive a free sample of this product?No Yes,I would recommend this product. Was this review helpful? (0) (24) Report review 4 out of 5 stars. Yep Jason VERIFIED PURCHASE 4 days ago I felt tingling and slightly erected, but I am a 53 year old! Did you receive a free sample of this product?No Yes,I would recommend this product. | petroc | |
04/10/2023 08:42 | LOL, this latest review on Amazon says it all: "Tim L 1.0 out of 5 stars Absolute rubbish, a real snake oil con Reviewed in the United Kingdom on 2 October 2023 Verified Purchase This product might work for someone with performance anxiety, placebo style, but if your problem is medical just forget it. Do not waste your money. Amazon shouldn't have junk like this on their website" | thebutler | |
04/10/2023 08:27 | all I know ask two friends to try both over the moon on the results. best way to check sales go into your local boots and ask the girl behind the counter how are sales going that's what I did the answer was steady sales | goldie40 | |
04/10/2023 06:01 | "If they work"? | glavey | |
03/10/2023 22:06 | Amazon: Terry Venables 5.0 out of 5 stars If they work Reviewed in the United Kingdom on 1 October 2023 Verified Purchase Very happy this product so easy to use | petroc | |
03/10/2023 22:04 | Boots: 5 out of 5 stars. Game changer AlanB 7 days ago Game changer! For me and especially the missus, very happy new customer Did you receive a free sample of this product?No Yes,I would recommend this product. | petroc | |
03/10/2023 08:29 | Eroxon sales on Amazon now dropped to 1k a month, with the majority of reviews continuing to be negative, the latest: Mr. N.Graves 1.0 out of 5 stars Doesn’t do anything Reviewed in the United Kingdom on 1 October 2023 Verified Purchase This product had no noticeable affect at all tried it 3 times. Just nothing to report Don’t get your hopes up and keep your money in your pocket Disappointing | thebutler | |
02/10/2023 12:25 | Erexon: 259 out of 341 (76%) reviewers recommend this product Eroxon: 284 out of 383 (74.15%) reviewers don't recommend this product | glavey | |
02/10/2023 10:16 | Did other posters not show there are alternative methods being used to measure the cooling of hydroalcoholic gels ‘using a validated handheld thermal imaging system’? Still seems the major problem is if Futura’s hydroalcohoic Eroxon gel will show an effect beyond a Haleon placebo hydroalcoholic gel in a double blind placebo controlled study. This study does now seem to be required for Eroxon to ever be commercialised in the USA as the only ‘clinically proven’ hydroalcoholic gel for ED. And a failure in that study means any similar hydroalcoholic can have the same effects in ED. So Eroxon would then no longer meet the the Haleon key performance obligation for Haleon to have to commercialise it. That is as the original RNS said being the ‘only clinically proven gel treatment for ED’. No matter if its in the USA or EU. Or even if the cooling of the gel composition is measured by sticking a thermometer on a beaker or using a handheld thermal device. Haleon will have proven any similar placebo hydroalcoholic gel to Dermasys can have the same effect in ED. | mdi | |
02/10/2023 08:51 | excellent news, bodes well for patent protection in other jurisdictions. | bg23 | |
02/10/2023 08:39 | LOL! The MMs have hardly ticked it up! Still very weak, this will end up down by the close, mark my words! | thebutler | |
02/10/2023 08:29 | Is this the patent granted? Its to do with ‘methods of measuring the cooling abaility of a topical composition’? | mdi | |
02/10/2023 08:05 | BINGO Final piece of the puzzle patent until 2024 200p price target | j777j | |
02/10/2023 07:27 | Great news :-) | broomrigg |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions